| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/13/2007 | US20070212717 Method for Inhibiting Hepatitis C Virus Replication |
| 09/13/2007 | US20070212716 Nezara viridula Ecdysone Receptor |
| 09/13/2007 | US20070212715 Bacteria detection device, bacteria detection method and bacteria detection kit |
| 09/13/2007 | US20070212714 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 09/13/2007 | US20070212713 Polymorphisms in growth hormone receptor, ghrelin, leptin, neuropeptide Y, and uncoupling protein 2 genes and their associations with measures of performance and carcass merit in beef cattle |
| 09/13/2007 | US20070212712 Methods for identifying modulators of hedgehog autoprocessing |
| 09/13/2007 | US20070212711 P1-34 Expression Units |
| 09/13/2007 | US20070212710 Competitive hybridization of dna probes and method of using the same |
| 09/13/2007 | US20070212709 Non-nucleosidic linker linking xanthene donor to 4,7-dichlororhodamine acceptor; |
| 09/13/2007 | US20070212708 Method for the Production of a Solution, Associated Arrangement and Uses of the Method and Arrangement |
| 09/13/2007 | US20070212707 Cell cycle markers |
| 09/13/2007 | US20070212706 Novel alkaline proteases and detergents and cleaners comprising these novel alkaline proteases |
| 09/13/2007 | US20070212705 Pseudomonas aeruginosa l-d carboxypeptidase a, expression and activity |
| 09/13/2007 | US20070212704 Compositions, methods, and kits for amplifying nucleic acids |
| 09/13/2007 | US20070212702 Recurrent gene fusions in prostate cancer |
| 09/13/2007 | US20070212701 Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof |
| 09/13/2007 | US20070212700 Methods of using and analyzing biological sequence data |
| 09/13/2007 | US20070212699 Process for high throughput DNA methylation analysis |
| 09/13/2007 | US20070212698 Operator independent programmable sample preparation and analysis system |
| 09/13/2007 | US20070212697 For analysis of ligated RNA; employed in methods for labeling RNA by contacting a sample containing RNA with an enzyme having an RNA ligation activity in the presence of the labeled nucleotide composition |
| 09/13/2007 | US20070212696 for detecting von Willebrand factor degrading enzyme activity in a biological sample |
| 09/13/2007 | US20070212695 Compositions, methods, and kits for selective amplification of nucleic acids |
| 09/13/2007 | US20070212694 Polymorphisms In The Nod2/Card15 Gene |
| 09/13/2007 | US20070212693 Factor reca from bacillus licheniformis and reca-inactivated safety stems used for biotechnological production |
| 09/13/2007 | US20070212692 Generation Of Recombinant Genes In Prokaryotic Cells By Using Two Extrachromosomal Elements |
| 09/13/2007 | US20070212691 Cytolethal Distending Toxins and Detection of Campylobacter Bacteria Using the Same as a Target |
| 09/13/2007 | US20070212690 Folate Antagonists Having Improved Selectivity |
| 09/13/2007 | US20070212689 Prenatal Diagnosis Using Cell-Free Fetal DNA in Amniotic Fluid |
| 09/13/2007 | US20070212688 Method For Distinguishing Cbf-Positive Aml Subtypes From Cbf-Negative Aml Subtypes |
| 09/13/2007 | US20070212687 Method For Distinguishing Mll-Ptd-Positive Aml From Other Aml Subtypes |
| 09/13/2007 | US20070212686 Use Of T-Cadherin As A Target |
| 09/13/2007 | US20070212685 Utilizing SCN9A (sodium channel alpha subunits) gene and expression products thereof for the screening and identification of therapeutic agents; in vitro method for identifying a selective inhibitor of human SCN9A |
| 09/13/2007 | US20070212684 Diagnostic Test Kits |
| 09/13/2007 | US20070212683 Co-crystals and pharmaceutical compositions comprising the same |
| 09/13/2007 | US20070212682 Methods And Apparatus For Detection Of Viral Infection |
| 09/13/2007 | US20070212681 Cell canaries for biochemical pathogen detection |
| 09/13/2007 | US20070212680 Safety approach for diagnostic systems |
| 09/13/2007 | US20070212679 Assay for parkinson's disease therapeutics and enzymatically active parkin preparations useful therein |
| 09/13/2007 | US20070212678 Method And Apparatus For Predicting Aggregation Kinetics Of A Biologically Active Material |
| 09/13/2007 | US20070212677 Identifying off-target effects and hidden phenotypes of drugs in human cells |
| 09/13/2007 | US20070212676 Induction of Myocardial Cell From Mammalian Bone Marrow Cell or Cord Blood-Derived Cell and Fat Tissue |
| 09/13/2007 | US20070212675 Flap Endonuclease (Fen1) Regulatory Sequences And Uses Thereof |
| 09/13/2007 | US20070212555 Preparation of Nanometric Arrays of Biomolecules on Oligo-or Poly(Ethylene Glycol) Films on Silicon Surfaces |
| 09/13/2007 | US20070212423 Stem cells that transform to beating cardiomyocytes |
| 09/13/2007 | US20070212378 Methods And Compositions For Mycoplasma Pneumoniae Exotoxins |
| 09/13/2007 | US20070212374 Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus l1 proteins, and uses thereof |
| 09/13/2007 | US20070212369 Colon Specific Genes and Proteins |
| 09/13/2007 | US20070212368 Proteins |
| 09/13/2007 | US20070212353 Novel therapeutic target and diagnostic marker for asthma and related conditions |
| 09/13/2007 | US20070212351 Novel therapeutic targets in cancer |
| 09/13/2007 | US20070212345 Methods And Compositions For The Prevention And Treatment Of Gentiourinary Disorders Including Pre-Term Labor And Leiomyomas |
| 09/13/2007 | US20070212344 Pharmaceutical preparation with RNA as hemostasis cofactor |
| 09/13/2007 | US20070212299 A gene (designated 161P2F10B) and its encoded protein which exhibits tissue specific expression in normal adult tissue and is aberrantly expressed in the cancers; medical diagnostis;, prognosis, prophylactis and/or gene therapy; tissue-target therapy; used to elicit a humoral or cellular immune response |
| 09/13/2007 | US20070209572 High throughput screening of crystallization materials |
| 09/13/2007 | DE202007003707U1 Vorrichtung zum Nehmen von Proben aus Systemen mit flexiblen Wandungen und zum Eintragen von Fluiden in solche Apparatus for taking samples from systems with flexible walls and for introducing fluids into such |
| 09/13/2007 | DE102006012918A1 Test system, useful for the determination of the effectiveness of biologic and systemic therapies in psoriasis, comprises cells that express the human Thy-1 (CD90) |
| 09/13/2007 | DE102006011133A1 Chimäres Polypeptidmolekül The chimeric polypeptide molecule |
| 09/13/2007 | DE102006010958A1 Verfahren zur Durchführung einer Reaktion zur Vervielfältigung einer Nukleinsäure A method of performing a reaction for the amplification of a nucleic acid |
| 09/13/2007 | DE102004027865B4 Leitende Kohlenstoff-Nanotubes, dotiert mit einem Metall, und Verfahren zur Herstellung eines Biosensors, der diese benutzt Conductive carbon nanotubes, doped with a metal, and method for producing a biosensor that uses this |
| 09/13/2007 | CA2646987A1 Method and apparatus for target detection using electrode-bound viruses |
| 09/13/2007 | CA2645310A1 Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells |
| 09/13/2007 | CA2645277A1 Compositions and methods based on peptide binding profiling |
| 09/13/2007 | CA2645045A1 Specific amplification of fetal dna sequences from a mixed, fetal-maternal source |
| 09/13/2007 | CA2644995A1 Random rnai libraries, methods of generating same, and screening methods utilizing same |
| 09/13/2007 | CA2644926A1 A method for the preparation of recombinant human thrombin and fibrinogen |
| 09/13/2007 | CA2644856A1 Human embryonic stem cell methods and podxl expression |
| 09/13/2007 | CA2644855A1 Extracorporeal removal of microvesicular particles |
| 09/13/2007 | CA2644664A1 Methods of treating, reducing and inhibiting the appearance of ageing in the skin |
| 09/13/2007 | CA2644517A1 Genetic markers for predicting disease and treatment outcome |
| 09/13/2007 | CA2644262A1 Antisense antiviral compound and method for treating arenavirus infection |
| 09/13/2007 | CA2644162A1 Method for diagnosing and/or predicting the development of an allergic disorder and agents for treating and/or preventing same |
| 09/13/2007 | CA2643053A1 Polymorphisms in voltage-gated sodium channel alpha 1-subunit as markers for therapy selection |
| 09/13/2007 | CA2638844A1 Microrna expression profile associated with pancreatic cancer |
| 09/13/2007 | CA2638791A1 Gene encoding transcriptional inducer for maltase gene and maltose transporter gene and use thereof |
| 09/13/2007 | CA2638750A1 Methods and systems for evaluating health risk factors by measurement of dna damage and dna repair |
| 09/13/2007 | CA2633442A1 Compositions and methods related to controlled gene expression using viral vectors |
| 09/13/2007 | CA2631720A1 Antineoplasics activities of ellipticine and its derivatives |
| 09/13/2007 | CA2629008A1 Materials and methods for assaying for methylation of cpg islands associated with genes in the evaluation of cancer |
| 09/13/2007 | CA2613600A1 Natively glycosylated mammalian biological molecules produced by eletromagnetically stimulating living mammalian cells |
| 09/13/2007 | CA2606130A1 Gene encoding glycogen synthesis initiator and use thereof |
| 09/12/2007 | EP1832876A2 Non-invasive enzyme screen for tissue remodelling-associated conditions |
| 09/12/2007 | EP1832663A2 Uses of DNA-PK |
| 09/12/2007 | EP1832662A2 DNA encoding chondroitin synthase from Pasteurella multocida and methods of use |
| 09/12/2007 | EP1832661A1 Method for the individual staging of tumor diseases |
| 09/12/2007 | EP1832660A1 Method of screening antiobesity drug |
| 09/12/2007 | EP1832653A1 MN gene and protein |
| 09/12/2007 | EP1832290A2 Compositions and methods for use in targeting vascular destruction |
| 09/12/2007 | EP1831684A2 Lung cancer prognostics |
| 09/12/2007 | EP1831670A2 Nanoelectronic devices for dna detection, and recognition of polynucleotide sequences |
| 09/12/2007 | EP1831439A2 Microfluidic microarray assemblies and methods of manufacturing and using same |
| 09/12/2007 | EP1831404A2 Optoelectronic detection system |
| 09/12/2007 | EP1831403A2 Genetic markers of schizophrenia |
| 09/12/2007 | EP1831402A2 Genetic variants of vkorc1 predicting warfarin sensitivity |
| 09/12/2007 | EP1831401A2 Methods, compositions, and kits for forming self-complementary polynucleotides |
| 09/12/2007 | EP1831400A2 Id-tag complexes, arrays, and methods of use thereof |
| 09/12/2007 | EP1831399A2 Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders |
| 09/12/2007 | EP1831398A2 Method for measuring resistance or sensitivity to docetaxel |
| 09/12/2007 | EP1831397A1 Method for determining the function of nucleic acid sequences and expression products coded thereby |
| 09/12/2007 | EP1831396A2 Control sequences responding to amp and uses thereof |
| 09/12/2007 | EP1831395A1 Compositions and methods for treating schizophrenia and related disorders |